{
    "2020-05-10": [
        [
            {
                "time": "",
                "original_text": "贝达药业：贝成投资等股东合计拟减持不超过总股本2.94% 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝成投资",
                        "股东",
                        "减持",
                        "总股本",
                        "2.94%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：股东贝成投资等3人拟减持不超过总股本2.94% 拟减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝成投资",
                        "股东",
                        "减持",
                        "总股本",
                        "2.94%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}